Geriatrisches Zentrum

Zurück zum Hauptmenü
Zum Menü der Einrichtung

200
202
203
204
201

Adresse: Calwerstr. 14
72076 Tübingen

Telefonnummer: 07071 29-87517

Faxnummer: 07071 29-4628

Anfahrt Notfall

Publikationen von Mitarbeitern des GZ 2014

  • Benzinger P, Rapp K, Maetzler W, König HH, Jaensch A, Klenk J, Büchele G. Risk for femoral fractures in Parkinson's disease patients with and without severe functional impairment. PLoS One. 2014 May 22;9(5):e97073.
    Zum Abstract
  • Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H,Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T,Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S,Dickson DW, Singleton A, Hardy J. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet. 2014 Dec 1;23(23):6139-46.
    Zum Abstract
  • Brockmann K, Srulijes K, Pflederer S, Hauser AK, Schulte C, Maetzler W, Gasser T, Berg D. GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study. Mov Disord. 2014 Dec 1.
    Zum Abstract
  • Fritschi SK, Langer F, Kaeser SA, Maia LF, Portelius E, Pinotsi D, Kaminski
    CF, Winkler DT, Maetzler W, Keyvani K, Spitzer P, Wiltfang J, Kaminski Schierle GS, Zetterberg H, Staufenbiel M, Jucker M. Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid. Brain. 2014 Nov;137(Pt11):2909-15.
    Zum Abstract
  • Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, Lerche S, Eschweiler GW, Maetzler W, Berg D. Prodromal features for Parkinson's disease-baseline data from the TREND study. Eur J Neurol. 2014 May;21(5):766-72.
    Zum Abstract
  • Gerschütz A, Heinsen H, Grünblatt E, Wagner AK, Bartl J, Meissner C, Fallgatter AJ, Al-Sarraj S, Troakes C, Ferrer I, Arzberger T, Deckert J, Riederer P, Fischer M, Tatschner T, Monoranu CM. Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease. J Alzheimers Dis. 2014;40(1):135-42.
    Zum Abstract
  • Gräber S, Liepelt-Scarfone I, Csoti I, Maetzler W, Sultan F, Berg D.
    Post-cueing deficits with maintained cueing benefits in patients with Parkinson's disease dementia. Front Neurol. 2014 Nov 17;5:236.
    Zum Abstract
  • Hagen K, Ehlis AC, Haeussinger FB, Heinzel S, Dresler T, Mueller LD, Herrmann
    MJ, Fallgatter AJ, Metzger FG. Activation during the Trail Making Test measured with functional near-infrared spectroscopy in healthy elderly subjects.
    Neuroimage. 2014 Jan 15;85 Pt 1:583-91.
    Zum Abstract
  • Hagen K, Ehlis AC, Schneider S, Haeussinger FB, Fallgatter AJ, Metzger FG.
    Influence of different stimulation parameters on the somatosensory evoked potentials of the nervus vagus--how varied stimulation parameters affect VSEP. J
    Clin Neurophysiol. 2014 Apr;31(2):143-8.
    Zum Abstract
  • Hasmann SE, Berg D, Hobert MA, Weiss D, Lindemann U, Streffer J, Liepelt-Scarfone I, Maetzler W. Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controls. Front Aging Neurosci. 2014 Oct 24;6:286.
    Zum Abstract
  • Heinzel S, Liepelt-Scarfone I, Roeben B, Nasi-Kordhishti I, Suenkel U, Wurster I, Brockmann K, Fritsche A, Niebler R, Metzger FG, Eschweiler GW, Fallgatter AJ, Maetzler W, Berg D. A neurodegenerative vascular burden index and the impact on cognition. Front Aging Neurosci. 2014 Jul 9;6:161.
    Zum Abstract
  • Heni M, Schöpfer P, Peter A, Sartorius T, Fritsche A, Synofzik M, Häring HU, Maetzler W, Hennige AM.Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans.Acta Diabetol. 2014 Aug;51(4):679-81.
    Zum Abstract
  • Hobert MA, Maetzler W, Aminian K, Chiari L. Technical and clinical view on ambulatory assessment in Parkinson's disease. Acta Neurol Scand. 2014 Sep;130(3):139-47.
    Zum Abstract
  • Laske C, Stellos K. Vascular pathophysiology of Alzheimer's disease. Curr Alzheimer Res. 2014 Jan;11(1):1-3.
    Zum Abstract
  • Laske C. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. N Engl J Med. 2014 Apr 10;370(15):1459.
    Zum Abstract
  • Laske C, Stellos K, Kempter I, Stransky E, Maetzler W, Fleming I, Randriamboavonjy V. Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer's disease. Alzheimers Dement. 2014 Sep 4. pii: S1552-5260(14)02459-5.
    Zum Abstract
  • Lerche S, Hobert M, Brockmann K, Wurster I, Gaenslen A, Hasmann S, Eschweiler, GW, Maetzler W, Berg D. Mild parkinsonian signs in the elderly-is there an association with PD? Crossectional findings in 992 individuals. PLoS One. 2014 Mar 27;9(3):e92878.
    Zum Abstract
  • Louter M, Maetzler W, Prinzen J, van Lummel RC, Hobert M, Arends JB, Bloem, BR, Streffer J, Berg D, Overeem S, Liepelt-Scarfone I. Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controls. J Neurol Neurosurg Psychiatry. 2014 Apr 28.
    Zum Abstract
  • Maetzler W, Pilotto A, Apel A, Deuschle C, Kuebart G, Heinzel S, Liepelt-Scarfone I, Schulte C, Reusch D, Schleicher E, Rothfuss O, Schneider A, Dodel R, Gasser T, Berg D. In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody. Acta Neuropathol. 2014 Dec;128(6):893-5.
    Zum Abstract
  • Maetzler W, Karam M, Berger MF, Heger T, Maetzler C, Ruediger H, Bronzova J, Lobo PP, Ferreira JJ, Ziemssen T, Berg D. Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson's disease. J Neural Transm. 2014 Jul 20. [Epub ahead of print]
    Zum Abstract
  • Maetzler W, Apel A, Langkamp M, Deuschle C, Dilger SS, Stirnkorb JG, Schulte C, Schleicher E, Gasser T, Berg D. Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls. PLoS One. 2014 Feb 21;9(2):e88604.
    Zum Abstract
  • Maetzler W. Comment: why do nondopaminergic features in Parkinson disease matter? Neurology. 2014 Feb 4;82(5):417.
    Zum Abstract
  • Mielke MM Maetzler W. A 'bird's eye' view on the current status and potential benefits of blood biomarkers for Parkinson's disease. Biomark Med. 2014 Feb;8(2):225-7.
    Zum Abstract
  • Müller S, Mychajliw C, Hautzinger M, Fallgatter AJ, Saur R, Leyhe T.
    Memory for past public events depends on retrieval frequency but not memory age in Alzheimer's disease. J Alzheimers Dis. 2014;38(2):379-90.
    Zum Abstract
  • O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, Laske C, Breteler M, Shaw L, Trojanowski JQ, Schupf N, Rissman RA, Fagan AM, Oberoi P, Umek R, Weiner MW, Grammas P, Posner H, Martins R; STAR-B and BBBIG working groups. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimers Dement. 2014 Sep 27. pii: S1552-5260(14)02765-4.
    Zum Abstract
  • Polak T, Metzger FG, Deckert J, Fallgatter AJ. Central neural versus peripheral muscular origin of vagus somatosensory - evoked potentials. Brain Stimul. 2014 Jul-Aug;7(4):624-5. doi: 10.1016/j.brs.2014.04.003. Epub 2014 Apr 13. PubMed PMID: 24810954.
    Zum Abstract
  • Randriamboavonjy V, Sopova K, Stellos K, Laske C. Platelets as potential link between diabetes and Alzheimer's disease. Curr Alzheimer Res. 2014;11(9):862-8.
    Zum Abstract
  • Sopova K, Gatsiou K, Stellos K, Laske C. Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer's disease: from pathophysiology to novel treatment strategies. Curr Alzheimer Res. 2014 Jan;11(1):27-39. Review.
    Zum Abstract
  • Tzikas S, Schlak D, Sopova K, Gatsiou A, Stakos D, Stamatelopoulos K, Stellos K, Laske C. Increased myeloperoxidase plasma levels in patients with Alzheimer's disease. J Alzheimers Dis. 2014;39(3):557-64.
    Zum Abstract
  • van der Zee J, Van Langenhove T, Kovacs GG, Dillen L, Deschamps W, Engelborghs S, Matěj R, Vandenbulcke M, Sieben A, Dermaut B, Smets K, Van Damme P, Merlin C, Laureys A, Van Den Broeck M, Mattheijssens M, Peeters K, Benussi L, Binetti G, Ghidoni R, Borroni B, Padovani A, Archetti S, Pastor P, Razquin C, Ortega-Cubero S, Hernández I, Boada M, Ruiz A, de Mendonça A, Miltenberger-Miltényi G, do Couto FS, Sorbi S, Nacmias B, Bagnoli S, Graff C, Chiang HH, Thonberg H, Perneczky R, Diehl-Schmid J, Alexopoulos P, Frisoni GB, Bonvicini C, Synofzik M, Maetzler W, vom Hagen JM, Schöls L, Haack TB, Strom TM, Prokisch H, Dols-Icardo O, Clarimón J, Lleó A, Santana I, Almeida MR, Santiago B, Heneka MT, Jessen F, Ramirez A, Sanchez-Valle R, Llado A, Gelpi E, Sarafov S, Tournev I, Jordanova A, Parobkova E, Fabrizi GM, Testi S, Salmon E, Ströbel T, Santens P, Robberecht W, De Jonghe P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. 2014 Sep;128(3):397-410.
    Zum Abstract
  • Wilke C, Deuschle C, Rattay TW, Maetzler W, Synofzik M. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis. Neurobiol Aging. 2014 Oct 18.
    Zum Abstract

Zertifikate und Verbände

Focus: Top Nationales Krankenhaus 2024

Die deutschen Universitätsklinika

Kooperation für Transparenz und Qualität im Gesundheitswesen

Qualitätspartnerschaft mit der PKV

Blauer Sterne Betrieb

Erfolgsfaktor Familie

Die Altersvorsorge für den Öffentlichen Dienst